Patricia “Patti” Mae Doykos is the inaugural executive director for Global Health Equity at Bristol Myers Squibb. She has responsibility for the company’s $150M Health Equity Commitment as well as a number of domestic and global health partnerships to address health disparities. Internally, she is part of the team developing the company’s global health equity strategy and goals and leads the business integration efforts supporting BMS teams to embed a health equity lens in their work for patients across the lifecycle and enterprise. Centering health equity is an opportunity for BMS to expand and improve the quality of the company’s science and the reach and impact of its innovative therapies on patients, particularly for medically underserved patient populations.

Patti has 27 years of experience and leadership in transformative corporate philanthropy and corporate social responsibility, brand and strategic communications, policy advancement and health equity and social justice from her roles in the company and the Bristol Myers Squibb Foundation. She has developed and led numerous US and international grant-making and public-private partnership programs for global HIV/AIDS, women’s health, diabetes, cancer, serious mental illness, cardiovascular disease, immunology, and COVID19. Among her current service roles are inaugural chair of the board of the Center for Global Health Equity at Dartmouth-Geisel Medical School, Board of Advisors for Dartmouth-Geisel Medical School, Advisory Board for the Center for Global Health at Rutgers University, Board of Mercer County United Way, and advisor to the Global Solidarity Fund.

Patti received her BA for majors in Government and German from Dartmouth College, MA in German Literature & Language from the University of Virginia, and PhD in German Literature & Language with a Cultural Studies focus from New York University.